PalpationAdvocacyLymphoscintigraphyAdenocarcinomaFISHMastectomyCAMGeneticPredispositionAyurvedaCystLapatinibMastodyniaCheckpointInhibitorNeoadjuvantTherapyNodePositiveGermlineMutationER+PARPInhibitorsAromataseInhibitorsPagetDiseaseTumorGradeAdjuvantTherapyAngiogenesisDefinitiveSurgeryECOGScorePrecisionMedicineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytostaticCDK4/6InhibitorsNeoplasmBevacizumabBRCAGeneMRIPalbociclibInvasiveBreastCancermTORInhibitorsStagingTriplePositiveBreastCancerMegestrolAcetate5-FluorouracilDoxorubicinBrachytherapyBiopsyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltEGFR(epidermalgrowth factorreceptor)Down-StagingGailModelExcisionalBiopsyHER-2RaloxifeneSERMAxillarySamplingAntiemeticDoseDenseTherapyCMFChemotherapyLymphNodeStatusAnastrozoleAntibodyTherapyMorpheaFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.EstrogenNodeNegativeChemopreventionHormoneReceptorStatusDimplingLumpectomyLCISBI-RADSHerceptinPhysicalactivity mayreduce therisk of breastcancersGuaranteedRenewableInsuranceFamilyHistoryACChemotherapyAlopeciaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.CapecitabineFlowCytometryFibroadenomaPI3KinaseInhibitorsBOCAProgestinAbsoluteRiskEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearWomen ages40+ shouldhave a clinicalbreast examat least yearlyTyrosine-KinaseInhibitor1 in 8womenGeneticCounselingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCyclophosphamideIntraductalPapillomaOvarianSuppressionER-BreastTomosynthesisPaclitaxelBreastCancerMetastasisMultimodalityTherapyRADKi-67RateTripleNegativeBreastCancerBilateralProphylacticMastectomyMultifocalTumorsSelf-examinationGenomicTestingHormoneReplacementTherapyPathologicResponseCo-survivorImmunotherapyRadiotherapyKappaEpsilonPhyllodesTumorLumpEstradiolRelapseApoptosisBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ChemotherapyCytotoxicDocetaxelCalcificationsGeneMutationCachexiaTamoxifenIn-situCarcinomaMethotrexateOligometastasesPalpationAdvocacyLymphoscintigraphyAdenocarcinomaFISHMastectomyCAMGeneticPredispositionAyurvedaCystLapatinibMastodyniaCheckpointInhibitorNeoadjuvantTherapyNodePositiveGermlineMutationER+PARPInhibitorsAromataseInhibitorsPagetDiseaseTumorGradeAdjuvantTherapyAngiogenesisDefinitiveSurgeryECOGScorePrecisionMedicineAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCytostaticCDK4/6InhibitorsNeoplasmBevacizumabBRCAGeneMRIPalbociclibInvasiveBreastCancermTORInhibitorsStagingTriplePositiveBreastCancerMegestrolAcetate5-FluorouracilDoxorubicinBrachytherapyBiopsyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltEGFR(epidermalgrowth factorreceptor)Down-StagingGailModelExcisionalBiopsyHER-2RaloxifeneSERMAxillarySamplingAntiemeticDoseDenseTherapyCMFChemotherapyLymphNodeStatusAnastrozoleAntibodyTherapyMorpheaFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.EstrogenNodeNegativeChemopreventionHormoneReceptorStatusDimplingLumpectomyLCISBI-RADSHerceptinPhysicalactivity mayreduce therisk of breastcancersGuaranteedRenewableInsuranceFamilyHistoryACChemotherapyAlopeciaWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.CapecitabineFlowCytometryFibroadenomaPI3KinaseInhibitorsBOCAProgestinAbsoluteRiskEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearWomen ages40+ shouldhave a clinicalbreast examat least yearlyTyrosine-KinaseInhibitor1 in 8womenGeneticCounselingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCyclophosphamideIntraductalPapillomaOvarianSuppressionER-BreastTomosynthesisPaclitaxelBreastCancerMetastasisMultimodalityTherapyRADKi-67RateTripleNegativeBreastCancerBilateralProphylacticMastectomyMultifocalTumorsSelf-examinationGenomicTestingHormoneReplacementTherapyPathologicResponseCo-survivorImmunotherapyRadiotherapyKappaEpsilonPhyllodesTumorLumpEstradiolRelapseApoptosisBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ChemotherapyCytotoxicDocetaxelCalcificationsGeneMutationCachexiaTamoxifenIn-situCarcinomaMethotrexateOligometastases

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Palpation
  2. Advocacy
  3. Lymphoscintigraphy
  4. Adenocarcinoma
  5. FISH
  6. Mastectomy
  7. CAM
  8. Genetic Predisposition
  9. Ayurveda
  10. Cyst
  11. Lapatinib
  12. Mastodynia
  13. Checkpoint Inhibitor
  14. Neoadjuvant Therapy
  15. Node Positive
  16. Germline Mutation
  17. ER+
  18. PARP Inhibitors
  19. Aromatase Inhibitors
  20. Paget Disease
  21. Tumor Grade
  22. Adjuvant Therapy
  23. Angiogenesis
  24. Definitive Surgery
  25. ECOG Score
  26. Precision Medicine
  27. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  28. Cytostatic
  29. CDK4/6 Inhibitors
  30. Neoplasm
  31. Bevacizumab
  32. BRCA Gene
  33. MRI
  34. Palbociclib
  35. Invasive Breast Cancer
  36. mTOR Inhibitors
  37. Staging
  38. Triple Positive Breast Cancer
  39. Megestrol Acetate
  40. 5-Fluorouracil
  41. Doxorubicin
  42. Brachytherapy
  43. Biopsy
  44. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  45. EGFR (epidermal growth factor receptor)
  46. Down-Staging
  47. Gail Model
  48. Excisional Biopsy
  49. HER-2
  50. Raloxifene
  51. SERM
  52. Axillary Sampling
  53. Antiemetic
  54. Dose Dense Therapy
  55. CMF Chemotherapy
  56. Lymph Node Status
  57. Anastrozole
  58. Antibody Therapy
  59. Morphea
  60. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  61. Estrogen
  62. Node Negative
  63. Chemoprevention
  64. Hormone Receptor Status
  65. Dimpling
  66. Lumpectomy
  67. LCIS
  68. BI-RADS
  69. Herceptin
  70. Physical activity may reduce the risk of breast cancers
  71. Guaranteed Renewable Insurance
  72. Family History
  73. AC Chemotherapy
  74. Alopecia
  75. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  76. Capecitabine
  77. Flow Cytometry
  78. Fibroadenoma
  79. PI3 Kinase Inhibitors
  80. BOCA
  81. Progestin
  82. Absolute Risk
  83. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  84. Women ages 40+ should have a clinical breast exam at least yearly
  85. Tyrosine-Kinase Inhibitor
  86. 1 in 8 women
  87. Genetic Counseling
  88. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  89. Cyclophosphamide
  90. Intraductal Papilloma
  91. Ovarian Suppression
  92. ER-
  93. Breast Tomosynthesis
  94. Paclitaxel
  95. Breast Cancer
  96. Metastasis
  97. Multimodality Therapy
  98. RAD
  99. Ki-67 Rate
  100. Triple Negative Breast Cancer
  101. Bilateral Prophylactic Mastectomy
  102. Multifocal Tumors
  103. Self-examination
  104. Genomic Testing
  105. Hormone Replacement Therapy
  106. Pathologic Response
  107. Co-survivor
  108. Immunotherapy
  109. Radiotherapy
  110. Kappa Epsilon
  111. Phyllodes Tumor
  112. Lump
  113. Estradiol
  114. Relapse
  115. Apoptosis
  116. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  117. Chemotherapy
  118. Cytotoxic
  119. Docetaxel
  120. Calcifications
  121. Gene Mutation
  122. Cachexia
  123. Tamoxifen
  124. In-situ Carcinoma
  125. Methotrexate
  126. Oligometastases